The impact of CYP3A4 and CYP3A5 genetic variations on tacrolimus treatment of living‐donor Egyptian kidney transplanted patients
出版年份 2023 全文链接
标题
The impact of CYP3A4 and CYP3A5 genetic variations on tacrolimus treatment of living‐donor Egyptian kidney transplanted patients
作者
关键词
-
出版物
JOURNAL OF CLINICAL LABORATORY ANALYSIS
Volume -, Issue -, Pages -
出版商
Wiley
发表日期
2023-10-04
DOI
10.1002/jcla.24969
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Insights into the Pharmacogenetics of Tacrolimus Pharmacokinetics and Pharmacodynamics
- (2022) Mercè Brunet et al. Pharmaceutics
- Predictors of tacrolimus pharmacokinetic variability: current evidences and future perspectives
- (2020) Alexandra Degraeve et al. Expert Opinion on Drug Metabolism & Toxicology
- The Clinical Impact of the C0/D Ratio and the CYP3A5 Genotype on Outcome in Tacrolimus Treated Kidney Transplant Recipients
- (2020) Teun van Gelder et al. Frontiers in Pharmacology
- CYP3A5 Gene-Guided Tacrolimus Treatment of Living-Donor Egyptian Kidney Transplanted Patients
- (2020) Effrosyni Mendrinou et al. Frontiers in Pharmacology
- Tacrolimus troughs and genetic determinants of metabolism in kidney transplant recipients: A comparison of four ancestry groups
- (2019) Moataz E. Mohamed et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Therapeutic Drug Monitoring of Tacrolimus-Personalized Therapy
- (2019) Mercè Brunet et al. THERAPEUTIC DRUG MONITORING
- CYP3A5*3 and ABCB1 61A>G Significantly Influence Dose-adjusted Trough Blood Tacrolimus Concentrations in the First Three Months Post-Kidney Transplantation
- (2018) Rong Hu et al. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY
- Pharmacokinetics, Pharmacodynamics and Pharmacogenetics of Tacrolimus in Kidney Transplantation
- (2018) Meng Yu et al. CURRENT DRUG METABOLISM
- The combination of CYP3A4*22 and CYP3A5*3 single-nucleotide polymorphisms determines tacrolimus dose requirement after kidney transplantation
- (2017) Nuria Lloberas et al. Pharmacogenetics and Genomics
- Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines forCYP3A5Genotype and Tacrolimus Dosing
- (2015) KA Birdwell et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Multigene predictors of tacrolimus exposure in kidney transplant recipients
- (2015) Rebecca A Pulk et al. PHARMACOGENOMICS
- CYP3A5andCYP3A4, but notABCB1polymorphisms affect tacrolimus dose-adjusted trough concentrations in kidney transplant recipients
- (2014) Mateusz Kurzawski et al. PHARMACOGENOMICS
- Clinical implementation of pharmacogenetics in kidney transplantation: calcineurin inhibitors in the starting blocks
- (2013) Laure Elens et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- CYP3A5 Genotype, but Not CYP3A4*1b, CYP3A4*22, or Hematocrit, Predicts Tacrolimus Dose Requirements in Brazilian Renal Transplant Patients
- (2013) A B Santoro et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Impact of donor and recipient CYP3A5 and ABCB1 genetic polymorphisms on tacrolimus dosage requirements and rejection in Caucasian Spanish liver transplant patients
- (2013) Miguel Angel Gómez-Bravo et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Impact of CYP3A4*22 Allele on Tacrolimus Pharmacokinetics in Early Period After Renal Transplantation
- (2013) Laure Elens et al. THERAPEUTIC DRUG MONITORING
- Pharmacogenetic considerations for optimizing tacrolimus dosing in liver and kidney transplant patients
- (2013) Alessio Provenzani WORLD JOURNAL OF GASTROENTEROLOGY
- Drug–Drug Interactions Between Antiretroviral and Immunosuppressive Agents in HIV-Infected Patients After Solid Organ Transplantation: A Review
- (2012) Erik M. van Maarseveen et al. AIDS PATIENT CARE AND STDS
- A New Functional CYP3A4 Intron 6 Polymorphism Significantly Affects Tacrolimus Pharmacokinetics in Kidney Transplant Recipients
- (2011) L. Elens et al. CLINICAL CHEMISTRY
- Pharmacogenetics: From Bench to Byte— An Update of Guidelines
- (2011) J J Swen et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Effect of a new functionalCYP3A4polymorphism on calcineurin inhibitors’ dose requirements and trough blood levels in stable renal transplant patients
- (2011) Laure Elens et al. PHARMACOGENOMICS
- Novel Polymorphisms Associated With Tacrolimus Trough Concentrations: Results From a Multicenter Kidney Transplant Consortium
- (2011) Pamala A. Jacobson et al. TRANSPLANTATION
- Intronic polymorphism in CYP3A4 affects hepatic expression and response to statin drugs
- (2010) D Wang et al. PHARMACOGENOMICS JOURNAL
- Pharmacokinetic Optimization of Immunosuppressive Therapy in Thoracic Transplantation: Part I
- (2009) Caroline Monchaud et al. CLINICAL PHARMACOKINETICS
- New Insights Into the Pharmacokinetics and Pharmacodynamics of the Calcineurin Inhibitors and Mycophenolic Acid: Possible Consequences for Therapeutic Drug Monitoring in Solid Organ Transplantation
- (2009) Hylke de Jonge et al. THERAPEUTIC DRUG MONITORING
- CYP3A5 genotype is not associated with a higher risk of acute rejection in tacrolimus-treated renal transplant recipients
- (2008) Dennis A. Hesselink et al. Pharmacogenetics and Genomics
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More